STOCK TITAN

CONSTELLATION ACQ CRP UTS (CSTUF) Financials

CSTUF
FY2025 annual
Revenue Not reported for FY2025
Net Income -$3.2M n/m YoY
EPS (Diluted) Not reported for FY2025
Operating Cash Flow -$470K n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 17, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CSTUF SEC filings page.

This page shows CONSTELLATION ACQ CRP UTS (CSTUF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CSTUF FY2025

The reported vehicle has contracted sharply, while liabilities still exceed assets and annual losses continue despite minimal operating activity.

Between FY2021 and FY2025, total assets fell from $310.7M to $901K, while liabilities still stood at $24.2M; the result was negative equity of $23.3M. This combination describes a shrinking transaction vehicle whose obligations did not disappear as its asset base contracted.

The absence of reported revenue and the FY2025 net loss of $3.2M identify a transaction vehicle rather than a conventional operating business. Operating cash flow was -$470K, so the accounting loss was accompanied by cash leaving the entity, although the smaller cash outflow means the loss was not a one-for-one cash expense.

The latest balance sheet is dominated by a short-term funding imbalance: current assets were only $42K against current liabilities of $9.9M, producing a current ratio of 0.0042. Alongside negative equity, this indicates that the reported asset base provides very little coverage for obligations due within the operating cycle.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

CONSTELLATION ACQ CRP UTS does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
1/5

CONSTELLATION ACQ CRP UTS passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$3.3M
YoYn/m
QoQn/m

CONSTELLATION ACQ CRP UTS reported a net loss of $3.3M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$18K
YoY+265.9%
QoQ+250.0%
5Y CAGR-57.4%

CONSTELLATION ACQ CRP UTS held $18K in cash as of Q2 2026; no long-term debt figure is on record for that period.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Shares Outstanding

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

Share Buybacks
$0
YoYn/m
QoQ-100.0%

CONSTELLATION ACQ CRP UTS repurchased no shares in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 100.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

CSTUF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSTUF quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
SG&A Expenses$1.1M+325.3%$2.0M+371.6%N/A$248K+1.4%$265K+17.4%$415K-47.4%N/A$245K-66.5%
Operating Income-$1.1Mn/m-$2.0Mn/mN/A-$248Kn/m-$265Kn/m-$415Kn/mN/A-$245Kn/m
Net Income-$3.3Mn/m-$687Kn/mN/A-$1.3M-3631.2%-$221K-207.8%-$447Kn/mN/A$38K-87.7%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CSTUF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSTUF quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$691K-19.3%$682K-19.5%$901K-96.8%$873K-96.9%$856K-96.9%$847K-96.8%$28.2M-43.5%$27.8M-43.2%
Current Assets$30K-24.8%$40K-24.8%$42K-32.2%$35K-73.9%$40K-19.0%$54K-58.9%$62K+66.6%$135K-14.8%
Cash & Equivalents$18K+265.9%$5K-43.9%$5K-6.4%$9K+55.5%$5K-31.2%$9K+137.0%$5K+49.8%$6K+356.6%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$21.4M-0.4%$24.6M+16.0%$24.2M-49.7%$22.9M-51.6%$21.5M-53.5%$21.3M-53.4%$48.0M-28.9%$47.2M-27.5%
Current Liabilities$13.0M+37.1%$11.9M+28.8%$9.9M+12.6%$9.8M+16.1%$9.5M+20.1%$9.2M+21.5%$8.8M+34.4%$8.4M+67.3%
Non-Current Liabilities$8.4M-30.0%$12.8M+6.2%$14.2M-63.7%$13.1M-66.2%$12.0M-68.7%$12.0M-68.4%$39.2M-35.7%$38.8M-35.4%
Total Equity-$20.7Mn/m-$24.0Mn/m-$23.3Mn/m-$22.0Mn/m-$20.6Mn/m-$20.4Mn/m-$19.9Mn/m-$19.4Mn/m
Retained Earnings-$20.7Mn/m-$24.0Mn/m-$23.3Mn/m-$22.0Mn/m-$20.6Mn/m-$20.4Mn/m-$19.9Mn/m-$19.4Mn/m

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

CSTUF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSTUF quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$247Kn/m-$140Kn/m-$94Kn/m-$86Kn/m-$109Kn/m-$181Kn/m-$75Kn/m-$226Kn/m
Investing Cash Flow-$15Kn/m$223K-$15Kn/m-$15Kn/m-$15Kn/mN/A-$165Kn/m-$165Kn/m
Financing Cash Flow$275K+129.2%-$83K$105K-56.3%$105K-73.1%$120K-54.7%N/A$240K-69.4%$390K-18.9%
Share Buybacks$0n/m$238K$0n/m$0n/m$0n/mN/A$0n/m$0n/m

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.

CSTUF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSTUF quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Assets-471.1%-445.3pp-100.8%-48.0ppN/A-152.4%-152.6pp-25.8%-26.6pp-52.8%-50.9ppN/A0.1%-0.5pp
Current Ratio0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x0.010.0x0.010.0x0.020.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$23.3M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Is CONSTELLATION ACQ CRP UTS profitable?

No, CONSTELLATION ACQ CRP UTS (CSTUF) reported a net loss of $3.2M in fiscal year 2025.

What is CONSTELLATION ACQ CRP UTS's operating cash flow?

CONSTELLATION ACQ CRP UTS (CSTUF) recorded an outflow of $470K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are CONSTELLATION ACQ CRP UTS's total assets?

CONSTELLATION ACQ CRP UTS (CSTUF) had $901K in total assets as of fiscal year 2025, including both current and long-term assets.

CONSTELLATION ACQ CRP UTS (CSTUF) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

CONSTELLATION ACQ CRP UTS (CSTUF) had a return on assets of -359.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

CONSTELLATION ACQ CRP UTS (CSTUF) has negative shareholder equity of -$23.3M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

CONSTELLATION ACQ CRP UTS (CSTUF) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Back to top